back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-05 17:11 Tx date 2023-06-01 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+56,238 vol |
229,388 | |
| Filed 2023-05-17 18:07 Tx date 2023-05-17 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$620,000
+1,240,000 vol $0.50 each |
1,711,374 | |
| Filed 2023-03-28 12:22 Tx date 2023-03-24 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+28,169 vol |
471,374 | |
| Filed 2023-03-28 12:20 Tx date 2023-03-24 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$100,000 vol |
$100,000 | |
| Filed 2023-03-28 12:17 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-28 12:13 Tx date 2022-10-06 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,062
+12,500 vol $0.325 each |
173,150 | |
| Filed 2022-09-16 16:38 Tx date 2022-09-13 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$65,020
+162,550 vol $0.40 each |
162,550 | |
| Filed 2022-09-16 16:36 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-16 16:34 Tx date 2022-09-13 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$130,000
+325,000 vol $0.40 each |
443,205 | |
| Filed 2022-09-16 16:32 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
118,205 | ||
| Filed 2022-06-23 10:30 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
160,650 | ||
| Filed 2022-06-23 10:28 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
118,205 | ||
| Filed 2020-09-24 11:33 Tx date 2020-09-22 |
$ICO
iCo Therapeutics Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,750
+50,000 vol $0.035 each |
1,533,556 | |
| Filed 2020-09-24 11:32 Tx date 2020-09-22 |
$ICO
iCo Therapeutics Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,201
+235,000 vol $0.0349 each |
1,483,556 | |
| Filed 2020-09-24 11:30 Tx date 2020-09-22 |
$ICO
iCo Therapeutics Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,492
+272,000 vol $0.0349 each |
1,248,556 | |
| Filed 2020-09-14 14:41 Tx date 2020-09-11 |
$ICO
iCo Therapeutics Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,744
+273,556 vol $0.35 each |
976,556 | |
| Filed 2020-01-17 13:13 Tx date 2020-01-10 |
$ICO
iCo Therapeutics Inc. |
Jarosz, William Wasyl
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,000
+400,000 vol $0.08 each |
900,000 |